Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Rivaflo 20mg Tablets | 100-Count | RIVAROXABAN
Pharma

Rivaflo 20mg Tablets | 100-Count | RIVAROXABAN

$150

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse RIVAROXABAN — 20mg per tablet, 100-count pack. Direct oral anticoagulant for stroke prevention in AF, DVT/PE treatment and prevention, post-surgical thromboprophylaxis, and cardiovascular event reduction in CAD/PAD. Key warning: Spinal epidural hematoma risk with neuraxial anesthesia. Strong CYP3A4/P-gp inhibitors greatly increase exposure. Reduce dose/avoid in renal impairment. No antidote until andexanet alfa (expensive).

SKU
VES-002777-RIVAFLO-20MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Rivaflo 20mg (RIVAROXABAN)?

Direct oral anticoagulant for stroke prevention in AF, DVT/PE treatment and prevention, post-surgical thromboprophylaxis, and cardiovascular event reduction in CAD/PAD.

How it Works

Direct Factor Xa inhibitor — blocks final common pathway of coagulation. Predictable pharmacokinetics allow fixed dosing without monitoring.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
RIVAROXABAN
Dose per Tablet
20MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Bleeding (primary risk — GI bleeding, intracranial hemorrhage), anemia, nausea, elevated liver enzymes.

Safety Warnings

Spinal epidural hematoma risk with neuraxial anesthesia. Strong CYP3A4/P-gp inhibitors greatly increase exposure. Reduce dose/avoid in renal impairment. No antidote until andexanet alfa (expensive). International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.